He serves on the editorial board of several medical journals, and on the medical boards of the Myelodysplastic Syndrome Foundation, the Bone Marrow Foundation, and other foundations.
Our intentions are noble — put patients at the forefront of our myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) investigations to make their cure today's reality.
Dr. Mohan specializes in the treatment of myelodysplastic syndromes and acute myeloid leukemia, with a focus on clinical trials and on translational research into secondary leukemias.